Salmonella typhimurium engineered to produce CCL21 inhibit tumor growth

Cancer Immunology, Immunotherapy

Volumn 58, Issue 5, 2009, Pages 769-775

  Loeffler, Markus ^a   Le'Negrate, Gaelle ^a   Krajewska, Maryla ^a   Reed, John C ^a  

^a BURNHAM INSTITUTE   (United States)

Author keywords

Bacterial therapy; Cancer therapy; CCL21; Salmonella; Tumor targeting

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN; CXCL9 CHEMOKINE; GAMMA INTERFERON; GAMMA INTERFERON INDUCIBLE PROTEIN 10; SECONDARY LYMPHOID TISSUE CHEMOKINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN EXPRESSION; ANTINEOPLASTIC ACTIVITY; ARTICLE; BACTERIAL STRAIN; BIOENGINEERING; CANCER IMMUNOTHERAPY; CANCER INHIBITION; CANCER MODEL; CANCER RESISTANCE; CARCINOMA; CELL INFILTRATION; CONTROLLED STUDY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN CELL; INFLAMMATORY CELL; LUNG METASTASIS; MOUSE; MULTIDRUG RESISTANCE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SALMONELLA TYPHIMURIUM;

ADENOCARCINOMA; ANIMALS; BACTERIAL VACCINES; BREAST NEOPLASMS; CANCER VACCINES; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CELL LINE, TUMOR; CHEMOKINE CCL21; CHEMOKINES; COLONIC NEOPLASMS; CYTOKINES; FEMALE; IMMUNOTHERAPY, ACTIVE; LUNG NEOPLASMS; LYMPHOCYTES, TUMOR-INFILTRATING; MELANOMA, EXPERIMENTAL; MICE; MICE, INBRED BALB C; RECOMBINANT FUSION PROTEINS; SALMONELLA TYPHIMURIUM; VACCINES, ATTENUATED; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 61349195788     PISSN: 03407004     EISSN: 14320851     Source Type: Journal    
DOI: 10.1007/s00262-008-0555-9     Document Type: Article

References (31)

1. Coley WB (1991) The treatment of malignant tumors by repeated inoculations of erysipelas. With a report of ten original cases. 1893. Clin Orthop Relat Res (262):3-11
2. WB Coley JP Hoguet 1916 Melanotic cancer: with a report of 91 cases Ann Surg 64 2 206 241
3. WB Coley 1906 Late results of the treatment of inoperable sarcoma by the mixed toxins of Erysipelas and Bacillus prodigosus Am J Med Sci 131 375 430
4. HW Herr 1997 Tumour progression and survival in patients with T1G3 bladder tumours: 15-year outcome Br J Urol 80 5 762 765
5. AM Jackson AV Ivshina O Senko A Kuznetsova A Sundan MA O'Donnell 1998 Prognosis of intravesical bacillus Calmette-Guerin therapy for superficial bladder cancer by immunological urinary measurements: statistically weighted syndrome analysis J Urol 159 3 1054 1063
6. C Clairmont KC Lee J Pike M Ittensohn KB Low J Pawelek 2000 Biodistribution and genetic stability of the novel antitumor agent VNP20009, a genetically modified strain of Salmonella typhimurium J Infect Dis 181 6 1996 2002
7. SA Rosenberg PJ Spiess DE Kleiner 2002 Antitumor effects in mice of the intravenous injection of attenuated Salmonella typhimurium J Immunother 25 3 218 225
8. JF Toso VJ Gill P Hwu FM Marincola NP Restifo DJ Schwartzentruber 2002 Phase I study of the intravenous administration of attenuated Salmonella typhimurium to patients with metastatic melanoma J Clin Oncol 20 1 142 152
9. YA Yu S Shabahang TM Timiryasova Q Zhang R Beltz I Gentschev 2004 Visualization of tumors and metastases in live animals with bacteria and vaccinia virus encoding light-emitting proteins Nat Biotechnol 22 3 313 320
10. DH Thamm ID Kurzman I King Z Li M Sznol RR Dubielzig 2005 Systemic administration of an attenuated, tumor-targeting Salmonella typhimurium to dogs with spontaneous neoplasia: phase I evaluation Clin Cancer Res 11 13 4827 4834
11. MJ Carrier SN Chatfield G Dougan UT Nowicka D O'Callaghan JE Beesley 1992 Expression of human IL-1 beta in Salmonella typhimurium. A model system for the delivery of recombinant therapeutic proteins in vivo J Immunol 148 4 1176 1181
12. M Loeffler G Le'Negrate M Krajewska JC Reed 2007 Attenuated Salmonella engineered to produce human cytokine LIGHT inhibit tumor growth Proc Natl Acad Sci U S A 104 31 12879 12883
13. BJ Rollins 1997 Chemokines Blood 90 3 909 928
14. SA Kellermann S Hudak ER Oldham YJ Liu LM McEvoy 1999 The CC chemokine receptor-7 ligands 6Ckine and macrophage inflammatory protein-3 beta are potent chemoattractants for in vitro- and in vivo-derived dendritic cells J Immunol 162 7 3859 3864
15. M Nagira T Imai R Yoshida S Takagi M Iwasaki M Baba 1998 A lymphocyte-specific CC chemokine, secondary lymphoid tissue chemokine (SLC), is a highly efficient chemoattractant for B cells and activated T cells Eur J Immunol 28 5 1516 1523
16. CH Kim LM Pelus E Appelbaum K Johanson N Anzai HE Broxmeyer 1999 CCR7 ligands, SLC/6Ckine/Exodus2/TCA4 and CKbeta-11/MIP-3beta/ELC, are chemoattractants for CD56(+)CD16(-) NK cells and late stage lymphoid progenitors Cell Immunol 193 2 226 235
17. S Sharma M Stolina J Luo RM Strieter M Burdick LX Zhu 2000 Secondary lymphoid tissue chemokine mediates T cell-dependent antitumor responses in vivo J Immunol 164 9 4558 4563
18. SC Yang RK Batra S Hillinger KL Reckamp RM Strieter SM Dubinett 2006 Intrapulmonary administration of CCL21 gene-modified dendritic cells reduces tumor burden in spontaneous murine bronchoalveolar cell carcinoma Cancer Res 66 6 3205 3213
19. SC Yang S Hillinger K Riedl L Zhang L Zhu M Huang 2004 Intratumoral administration of dendritic cells overexpressing CCL21 generates systemic antitumor responses and confers tumor immunity Clin Cancer Res 10 8 2891 2901
20. H Soto W Wang M Strieter NG Copeland DJ Gilbert NA Jenkins 1998 The CC chemokine 6Ckine binds the CXC chemokine receptor CXCR3 Proc Natl Acad Sci U S A 95 14 8205 8210
21. AL Angiolillo C Sgadari DD Taub F Liao JM Farber S Maheshwari 1995 Human interferon-inducible protein 10 is a potent inhibitor of angiogenesis in vivo J Exp Med 182 1 155 162
22. C Sgadari AL Angiolillo G Tosato 1996 Inhibition of angiogenesis by interleukin-12 is mediated by the interferon-inducible protein 10 Blood 87 9 3877 3882
23. RM Strieter PJ Polverini DA Arenberg SL Kunkel 1995 The role of CXC chemokines as regulators of angiogenesis Shock 4 3 155 160
24. JM Wang X Deng W Gong S Su 1998 Chemokines and their role in tumor growth and metastasis J Immunol Methods 220 1-2 1 17
25. JE Galen J Nair JY Wang SS Wasserman MK Tanner MB Sztein 1999 Optimization of plasmid maintenance in the attenuated live vector vaccine strain Salmonella typhi CVD 908-htrA Infect Immun 67 12 6424 6433
26. M Loeffler JA Kruger AG Niethammer RA Reisfeld 2006 Targeting tumor-associated fibroblasts improves cancer chemotherapy by increasing intratumoral drug uptake J Clin Invest 116 7 1955 1962
27. GL Spitalny EA Havell 1984 Monoclonal antibody to murine gamma interferon inhibits lymphokine-induced antiviral and macrophage tumoricidal activities J Exp Med 159 5 1560 1565
28. G Valbuena DH Walker 2004 Effect of blocking the CXCL9/10-CXCR3 chemokine system in the outcome of endothelial-target rickettsial infections Am J Trop Med Hyg 71 4 393 399
29. G Shi S Partida-Sanchez RS Misra M Tighe MT Borchers JJ Lee 2007 Identification of an alternative G{alpha}q-dependent chemokine receptor signal transduction pathway in dendritic cells and granulocytes J Exp Med 204 11 2705 2718
30. K Flanagan D Moroziewicz H Kwak H Horig HL Kaufman 2004 The lymphoid chemokine CCL21 costimulates naive T cell expansion and Th1 polarization of non-regulatory CD4+ T cells Cell Immunol 231 1-2 75 84
31. Reed JC, Doctor KS, Godzik A (2004) The domains of apoptosis: a genomics perspective. Sci STKE 2004(239):RE9